Literature DB >> 8902678

Myocarditis: a clinical entity that can benefit from noninvasive imaging.

D Jain, B L Zaret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8902678     DOI： 10.1016/s1071-3581(96)90081-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  21 in total

Review 1.  Antimyosin cardiac imaging: will it play a role in the detection of doxorubicin cardiotoxicity?

Authors:  D Jain; B L Zaret
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

2.  Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation.

Authors:  M Ballester; D Obrador; I Carrió; C Moya; J M Augè; R Bordes; V Martí; I Bosch; L Bernà-Roqueta; M Estorch
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

3.  Myocarditis. A histopathologic definition and classification.

Authors:  H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

4.  Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies.

Authors:  B A Khaw; J T Fallon; G A Beller; E Haber
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

5.  Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate.

Authors:  B A Khaw; H W Strauss; R Moore; J T Fallon; T Yasuda; H K Gold; E Haber
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

6.  Antimyosin uptake and myofibrillarlysis in dilated cardiomyopathy.

Authors:  J Narula; J F Southern; G W Dec; I F Palacios; J B Newell; J T Fallon; H W Strauss; B A Khaw; T Yasuda
Journal:  J Nucl Cardiol       Date:  1995 Nov-Dec       Impact factor: 5.952

7.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

8.  Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trial.

Authors:  L L Johnson; D W Seldin; L C Becker; N D LaFrance; H A Liberman; C James; J A Mattis; R T Dean; J Brown; A Reiter
Journal:  J Am Coll Cardiol       Date:  1989-01       Impact factor: 24.094

9.  Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy.

Authors:  Y Seko; S Ishiyama; T Nishikawa; T Kasajima; M Hiroe; N Kagawa; K Osada; S Suzuki; H Yagita; K Okumura
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 10.  Myocarditis and idiopathic dilated cardiomyopathy.

Authors:  C A Brown; J B O'Connell
Journal:  Am J Med       Date:  1995-09       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.